000 01576 a2200433 4500
005 20250517192047.0
264 0 _c20190916
008 201909s 0 0 eng d
022 _a1473-4877
024 7 _a10.1080/03007995.2017.1419170
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFreeman, Robert
245 0 0 _aMirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study.
_h[electronic resource]
260 _bCurrent medical research and opinion
_c05 2018
300 _a785-793 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetanilides
_xtherapeutic use
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPatient Satisfaction
_xstatistics & numerical data
650 0 4 _aProspective Studies
650 0 4 _aQuality of Life
650 0 4 _aSurveys and Questionnaires
650 0 4 _aThiazoles
_xtherapeutic use
650 0 4 _aUrinary Bladder, Overactive
_xdrug therapy
700 1 _aFoley, Steve
700 1 _aRosa Arias, José
700 1 _aVicente, Eduardo
700 1 _aGrill, Robert
700 1 _aKachlirova, Zuzana
700 1 _aStari, Anny
700 1 _aHuang, Moses
700 1 _aChoudhury, Nurul
773 0 _tCurrent medical research and opinion
_gvol. 34
_gno. 5
_gp. 785-793
856 4 0 _uhttps://doi.org/10.1080/03007995.2017.1419170
_zAvailable from publisher's website
999 _c27902522
_d27902522